檢索結果 - M A Dimopoulos

Colon Adenoma Implicating Myasthenia Gravis: A Case Report of a Patient with Postcolectomy Complications 由 Y. Papachatzakis, E. Tseliou, I. Tatouli, I. Dialoupi, F. Michas, E. Papadopoulou, D. Kousouris, S. Kontogiannis, M. A. Dimopoulos

獲取全文

PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIP... 由 N. Munshi, A. Spencer, M. S. Raab, A. Masood, M. Martinez-Prieto, J. Chu, S. Iida, S. Lonial, M. A. Dimopoulos

獲取全文

S178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCI... 由 E. Terpos, M. Gavriatopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, D. Fotiou, N. Kanellias, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.-A. Dimopoulos

獲取全文

DP122 | ELRANATAMAB IN COMBINATION WITH DARATUMUMAB AND LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA NOT ELIGIBLE FOR TRANSPLANT: INITIAL RESULTS FROM MAGNETISMM-... 由 C. Liberatore, H. Quach, L. . Pour, S. Grosicki, H. Sia, J. Minarik, J Byun, C. Touzeau, S. Sullivan, E. Leip, E. Shaikh, A. Viqueira, M.A. Dimopoulos

獲取全文

B06 | BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE/DEXAMETHASONE IN NEWLY DIAGNOSED INTERMEDIATE-FIT AND FRAIL MULTIPLE MYELOMA: LONG-TERM EFFICACY AND SAFETY FROM THE PHASE 1/2 BELARD... 由 E. Terpos, M. Gavriatopoulou, I.N. Stathopoulos, P. Malandrakis, N. Kanellias, M. Migkou, F. Theodorakakou, E. Solia, E.E. Papaiakovou, E. Kastritis, M.A. Dimopoulos

獲取全文

P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK 由 E. Kastritis, M. C. Minnema, M. A. Dimopoulos, G. Merlini, F. Theodorakakou, D. Fotiou, A. Huart, K. Belhadj, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, G. Palladini

獲取全文

P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK 由 E. Kastritis, G. Palladini, M. A. Dimopoulos, A. Jaccard, G. Merlini, F. Theodorakakou, D. Fotiou, M. C. Minnema, A. Wechalekar, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, S. Schönland

獲取全文

Axitinib as a third or further line of treatment in renal cancer: a single institution experience 由 G. Tsironis, M. Liontos, A. Kyriazoglou, K. Koutsoukos, A. Tsiara, M. Kaparelou, R. Zakopoulou, A. Cohen, E. Skafida, S. Fontara, F. Zagouri, A. Bamias, M. A. Dimopoulos

獲取全文

B08: A THIRD BNT162B2 DOSE INDUCES ANTIBODY RESPONSES AGAINST SARS-COV-2 EVEN IN PREVIOUSLY NON-RESPONDERS WITH MULTIPLE MYELOMA 由 E Terpos, M Gavriatopoulou, I Ntanasis-Stathopoulos, A Briasoulis, S Gumeni, P Malandrakis, E-D Papanagnou, M Migkou, N Kanellias, E Kastritis, I P Trougakos, M A Dimopoulos

獲取全文

P1507: CLINICAL PROFILE OF COVID-19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS-COV-2 IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSAEMIA-THE EXP... 由 P. Delaporta, E. Terpos, E. E. Solomou, S. Gumeni, M.-I. Chatzielefteriou, K. Toutoudaki, D. Kyriakopoulou, N. Ioakeimidou, I. Ntanasis-Stathopoulos, I. Papassotiriou, I. P. Trougakos, M. A. Dimopoulos, A. Kattamis

獲取全文

P54 ORAL ANTIVIRALS RITONAVIR-NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID-19; A SINGLE-CENTER, PROSPECTIVE STUDY 由 V. Spiliopoulou, I. Ntanasis-Stathopoulos, P. Malandrakis, M. Gavriatopoulou, F. Theodorakakou, D. Fotiou, R. E. Syrigou, M. Migkou, M. Roussou, E. Eleutherakis-Papaiakovou, E. Kastritis, M. A Dimopoulos, E. Terpos

獲取全文

P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA 由 I. Ntanasis-Stathopoulos, M. Gavriatopoulou, E. Eleutherakis-Papaiakovou, P. Malandrakis, V. Spiliopoulou, R.E. Syrigou, F. Theodorakakou, D. Fotiou, M. Migkou, M. Roussou, E. Kastritis, M.A. Dimopoulos, E. Terpos

獲取全文

P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL 由 I. Ntanasis-Stathopoulos, M. Gavriatopoulou, P. Malandrakis, D. Fotiou, N. Kanellias, M. Migkou, F. Theodorakakou, V. Spiliopoulou, R. Syrigou, E. Eleutherakis-Papaiakovou, S. Gkolfinopoulos, K. Manousou, E. Kastritis, M.A. Dimopoulos, E. Terpos

獲取全文

P13 | ISATUXIMAB WITH BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOLLOWED BY ISATUXIMAB AND LENALIDOMIDE MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE... 由 E. Terpos, E. Kastritis, S. Delimpasi, K. Papathanasiou, V. Labropoulou, N. Kanellias, I.N. Stathopoulos, M. Migkou, E. Solia, F. Theodorakakou, E.E. Papaiakovou, M. Kotsopoulou, E. Katodritou, M. Gavriatopoulou, M.A. Dimopoulos

獲取全文

PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY M... 由 S. Delimpasi, H. Quach, M. Cavo, P. J. Ho, C. H.-S. Lee, A. Santoro, R. Schots, P. Vlummens, D. H. Yoon, S.-S. Yoon, C. D. Santos, D. Samineni, J. Huang, K. Wehrman, U. Patil, S. Sheikh, M. A. Dimopoulos

獲取全文

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP... 由 A. Spencer, P. Moreau, M.-V. Mateos, H. Goldschmidt, K. Suzuki, M.-D. Levin, P. Sonneveld, S.-S. Yoon, S. Z. Usmani, K. Weisel, D. Reece, T. Ahmadi, H. Pei, W. Garvin Mayo, X. Gai, J. Carey, R. Carson, M. A. Dimopoulos

獲取全文

P17 | EARLY TREATMENT RESPONSE EVALUATION WITH WHOLE BODY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AND FOCAL LESIONS 由 I. Ntanasis-Stathopoulos, V. Koutoulidis, M. Gavriatopoulou, M. Douka, P. Malandrakis, C. Filippatos, V. Spiliopoulou, F. Theodorakakou, I. Katsadouros, I. Solia, P. Boutsikos, M. Migkou, N. Kanellias, E. Eleutherakis-Papaiakovou, E. Kastritis, L.A. Moulopoulos, M.A. Dimopoulos, E. Terpos

獲取全文

P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL 由 T. Thomopoulos, A. Bouchla, A. Antoniadou, E. Terpos, M. Politou, K. Stamoulis, E. Koromboki, S. Papageorgiou, A. Kotanidou, I. Kalomenidis, E. Jahaj, S. Grigoropoulou, M. Pagoni, E. Grouzi, G. Poulakou, I. Trontzas, S. Labropoulou, A. Mentis, A. Bamias, S. Tsiodras, M.-A. Dimopoulos, V. Pappa

獲取全文

B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT-ELIGIBLE AND -INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA 由 P. Malandrakis, I. Ntanasis-Stathopoulos, I.V. Kostopoulos, P. Roussakis, E. Eleutherakis-Papaiakovou, C. Panteli, N. Angelis, V. Spiliopoulou, N. Orologas-Stavrou, F. Theodorakakou, D. Fotiou, M. Migkou, M. Gavriatopoulou, E. Kastritis, O.E. Tsitsilonis, M.A. Dimopoulos, E. Terpos

獲取全文

C003 | MODELING LONG-TERM PROGRESSION-FREE SURVIVAL IN TRANSPLANT-ELIGIBLE AND TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, BORTEZOMIB, LENALIDO... 由 F. Gay, P. Sonneveld, S. Zweegman, T. Facon, V. Hungria, N. J. Bahlis, P. Moreau, H. Einsele, M. Boccadoro, F. Borgsten, A. Lam, M. Nobrega, V. Kovacs, J. Wang, M. Rowe, A. Sitthi-Amorn, R. Carson, M.A. Dimopoulos, P. Rodríguez-Otero, S.Z. Usmani

獲取全文